Evidence map›Paper›PMID 39966655›Full record

ArticleNature biotechnology2025

Single-molecule live-cell RNA imaging with CRISPR-Csm.

Chenglong Xia, David Colognori, Xueyang Stephen Jiang, Ke Xu, Jennifer A Doudna

Abstract read
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Spligation enables programmable chimeric RNA generation in living cells.bioRxiv : the preprint server for biology · 2026
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Chenglong Xia *California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-5895-6342
David Colognori *Innovative Genomics Institute, University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-6995-7079
Xueyang Stephen JiangInnovative Genomics Institute, University of California, Berkeley, CA, USA.
Ke XuCalifornia Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-2788-194X
Jennifer A DoudnaCalifornia Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA. doudna@berkeley.edu.ORCID http://orcid.org/0000-0001-9161-999X

Funding

Targeting Viroporins and Coronavirus M ProteinU19AI171110 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nevan J Krogan · 2022 to 2026
$103.4M
Project 3U54AI170792 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nevan J Krogan · 2022 to 2026
$35.7M
RESEARCH PROJECT 2U19AI135990 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nevan J Krogan · 2018 to 2026
$21.4M
Resource Core II: In Vivo CoreU19NS132303 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI NIREN MURTHY · 2023 to 2026
$19.7M
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systemsU01AI142817 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BANFIELD, JILLIAN, DOUDNA, JENNIFER A · 2018 to 2022
$2.0M
Intracellular transport and organelle biology at the nanoscale: A multidimensional super-resolution approachR35GM149349 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Ke Xu · 2023 to 2026
$1.8M
Cas9 RNP delivery to immune cells in vivo via molecular targetingUH3AI150552 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI DOUDNA, JENNIFER A, WILSON, ROSS C · 2022 to 2022
$1.3M
Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery VehiclesR21HL173710 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI DOUDNA, JENNIFER A · 2024 to 2025
$520k
Identification and Characterization of Functional lncRNAs in human cellsK99GM151484 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI COLOGNORI, DAVID · 2024 to 2025
$236k
Howard Hughes Medical Institute (HHMI) D-0001NHLBI NIH HHS R21 HL173710NIAID NIH HHS U01 AI142817NIAID NIH HHS U19 AI135990NIAID NIH HHS U19 AI171110NIAID NIH HHS U54 AI170792NIAID NIH HHS UH3 AI150552NIGMS NIH HHS K99 GM151484NIGMS NIH HHS R35 GM149349NINDS NIH HHS U19 NS132303U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) D-0001U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) X-0001
6 · The paper itself

Abstract

Understanding the diverse dynamic behaviors of individual RNA molecules in single cells requires visualizing them at high resolution in real time. However, single-molecule live-cell imaging of unmodified endogenous RNA has not yet been achieved in a generalizable manner. Here, we present single-molecule live-cell fluorescence in situ hybridization (smLiveFISH), a robust approach that combines the programmable RNA-guided, RNA-targeting CRISPR-Csm complex with multiplexed guide RNAs for direct and efficient visualization of single RNA molecules in a range of cell types, including primary cells. Using smLiveFISH, we track individual native NOTCH2 and MAP1B transcripts in living cells and identify two distinct localization mechanisms including the cotranslational translocation of NOTCH2 mRNA at the endoplasmic reticulum and directional transport of MAP1B mRNA toward the cell periphery. This method has the potential to unlock principles governing the spatiotemporal organization of native transcripts in health and disease.

Indexed as

CRISPR-Cas SystemsIn Situ Hybridization, FluorescenceRNASingle Molecule ImagingAnimalsClustered Regularly Interspaced Short Palindromic RepeatsHumansMiceReceptor, Notch2RNA, Guide, CRISPR-Cas SystemsRNA, MessengerSingle-Cell AnalysisReceptor, Notch2RNARNA, Guide, CRISPR-Cas SystemsRNA, Messenger

Identifiers

PMID39966655
PMCPMC12700784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.